2016 Q1 Form 10-K Financial Statement
#000114420416081638 Filed on February 12, 2016
Income Statement
| Concept | 2016 Q1 | 2015 Q4 | 2014 Q4 |
|---|---|---|---|
| Revenue | $2.275M | $2.740M | $1.410M |
| YoY Change | 77.34% | 94.33% | 0.71% |
| Cost Of Revenue | $1.483M | $1.600M | $660.0K |
| YoY Change | 132.64% | 142.42% | 22.22% |
| Gross Profit | $792.7K | $1.140M | $750.0K |
| YoY Change | 22.77% | 52.0% | -12.79% |
| Gross Profit Margin | 34.84% | 41.61% | 53.19% |
| Selling, General & Admin | $3.832M | $3.390M | $2.350M |
| YoY Change | 27.67% | 44.26% | 54.61% |
| % of Gross Profit | 483.42% | 297.37% | 313.33% |
| Research & Development | $1.157M | $1.070M | $800.0K |
| YoY Change | 28.17% | 33.75% | 12.68% |
| % of Gross Profit | 145.92% | 93.86% | 106.67% |
| Depreciation & Amortization | $61.64K | $60.00K | $50.00K |
| YoY Change | 111.49% | 20.0% | 66.67% |
| % of Gross Profit | 7.78% | 5.26% | 6.67% |
| Operating Expenses | $4.989M | $4.460M | $3.160M |
| YoY Change | 27.78% | 41.14% | 41.07% |
| Operating Profit | -$4.196M | -$3.320M | -$2.410M |
| YoY Change | 28.77% | 37.76% | 74.64% |
| Interest Expense | $100.0K | $610.0K | -$500.0K |
| YoY Change | -91.6% | -222.0% | -78.54% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $0.00 | $0.00 | |
| YoY Change | |||
| Pretax Income | -$4.100M | -$2.710M | -$2.910M |
| YoY Change | 98.07% | -6.87% | -21.35% |
| Income Tax | $0.00 | ||
| % Of Pretax Income | |||
| Net Earnings | -$4.095M | -$2.710M | -$2.910M |
| YoY Change | 97.72% | -6.87% | -21.35% |
| Net Earnings / Revenue | -179.99% | -98.91% | -206.38% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$82.00M | -$67.75M | -$97.00M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 4.050M shares | 7.944M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2016 Q1 | 2015 Q4 | 2014 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $8.740M | $12.46M | $9.220M |
| YoY Change | 36.56% | 35.14% | 0.22% |
| Cash & Equivalents | $8.740M | $12.46M | $9.222M |
| Short-Term Investments | |||
| Other Short-Term Assets | $720.0K | $850.0K | $610.0K |
| YoY Change | 176.92% | 39.34% | 45.24% |
| Inventory | $1.510M | $1.089M | $679.7K |
| Prepaid Expenses | |||
| Receivables | $490.0K | $742.7K | $580.2K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $11.46M | $15.15M | $11.09M |
| YoY Change | 39.37% | 36.58% | 4.96% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $650.0K | $683.5K | $311.5K |
| YoY Change | 20.43% | 119.42% | 35.85% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $190.0K | $200.0K | $0.00 |
| YoY Change | -48.65% | ||
| Total Long-Term Assets | $850.0K | $887.2K | $312.1K |
| YoY Change | -6.4% | 184.27% | 35.56% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $11.46M | $15.15M | $11.09M |
| Total Long-Term Assets | $850.0K | $887.2K | $312.1K |
| Total Assets | $12.31M | $16.03M | $11.40M |
| YoY Change | 34.82% | 40.63% | 5.61% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.380M | $1.060M | $522.9K |
| YoY Change | 50.57% | 102.75% | 61.93% |
| Accrued Expenses | $1.880M | $1.055M | $1.265M |
| YoY Change | 46.17% | -16.55% | 45.36% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $3.270M | $3.257M | $2.698M |
| YoY Change | -1.47% | 20.7% | 63.73% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $190.0K | $280.0K | $5.320M |
| YoY Change | -95.4% | -94.74% | 172.82% |
| Total Long-Term Liabilities | $190.0K | $280.0K | $5.320M |
| YoY Change | -95.4% | -94.74% | 172.82% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.270M | $3.257M | $2.698M |
| Total Long-Term Liabilities | $190.0K | $280.0K | $5.320M |
| Total Liabilities | $3.460M | $3.537M | $8.015M |
| YoY Change | -53.55% | -55.87% | 122.53% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$163.6M | -$154.4M | |
| YoY Change | 5.95% | 5.3% | |
| Common Stock | $439.00 | $405.00 | $204.00 |
| YoY Change | -48.47% | 98.53% | -65.71% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $8.850M | $12.56M | $3.387M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $12.31M | $16.10M | $11.40M |
| YoY Change | 34.82% | 41.2% | 5.61% |
Cashflow Statement
| Concept | 2016 Q1 | 2015 Q4 | 2014 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$4.095M | -$2.710M | -$2.910M |
| YoY Change | 97.72% | -6.87% | -21.35% |
| Depreciation, Depletion And Amortization | $61.64K | $60.00K | $50.00K |
| YoY Change | 111.49% | 20.0% | 66.67% |
| Cash From Operating Activities | -$3.620M | -$3.480M | -$2.330M |
| YoY Change | 37.12% | 49.36% | 90.98% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $28.64K | $0.00 | -$160.0K |
| YoY Change | -83.65% | -100.0% | 166.67% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | ||
| YoY Change | |||
| Cash From Investing Activities | -$30.00K | $0.00 | -$160.0K |
| YoY Change | -83.33% | -100.0% | 166.67% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -80.00K | 6.830M | 10.00K |
| YoY Change | 68200.0% | -99.62% | |
| NET CHANGE | |||
| Cash From Operating Activities | -3.620M | -3.480M | -2.330M |
| Cash From Investing Activities | -30.00K | 0.000 | -160.0K |
| Cash From Financing Activities | -80.00K | 6.830M | 10.00K |
| Net Change In Cash | -3.730M | 3.350M | -2.480M |
| YoY Change | 32.27% | -235.08% | -282.35% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$3.620M | -$3.480M | -$2.330M |
| Capital Expenditures | $28.64K | $0.00 | -$160.0K |
| Free Cash Flow | -$3.649M | -$3.480M | -$2.170M |
| YoY Change | 29.61% | 60.37% | 87.07% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
3471782 | USD |
| CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16034490 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
5278806 | USD |
| CY2014 | us-gaap |
Revenues
Revenues
|
5512764 | USD |
| CY2015 | us-gaap |
Revenues
Revenues
|
7299830 | USD |
| CY2013 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2194259 | USD |
| CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2568602 | USD |
| CY2013 | us-gaap |
Gross Profit
GrossProfit
|
3084547 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
2944162 | USD |
| CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3894786 | USD |
| CY2014 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2913112 | USD |
| CY2015 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
7232971 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4225474 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4725123 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
10443387 | USD |
| CY2015Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
227172 | USD |
| CY2014Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
25048 | USD |
| CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3191479 | USD |
| CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2698148 | USD |
| CY2015Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
9635 | USD |
| CY2015Q4 | nuro |
Common Stock Warrants
CommonStockWarrants
|
280303 | USD |
| CY2014Q4 | nuro |
Common Stock Warrants
CommonStockWarrants
|
5307332 | USD |
| CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
8015115 | USD |
| CY2015Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
405 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
204 | USD |
| CY2015Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
176127932 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
157765209 | USD |
| CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-163565650 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-154378302 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12562708 | USD |
| CY2015 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3950746 | USD |
| CY2015 | us-gaap |
Gross Profit
GrossProfit
|
3349084 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3438218 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4075976 | USD |
| CY2013 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2779695 | USD |
| CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
15147270 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11090125 | USD |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
683534 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
311520 | USD |
| CY2015Q4 | us-gaap |
Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
|
203686 | USD |
| CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
|
585 | USD |
| CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1060135 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
522871 | USD |
| CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
848689 | USD |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12462872 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9221985 | USD |
| CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
885353 | USD |
| CY2015Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
742714 | USD |
| CY2014Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
580240 | USD |
| CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1055483 | USD |
| CY2015Q4 | us-gaap |
Inventory Net
InventoryNet
|
1089084 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
679740 | USD |
| CY2015Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
852600 | USD |
| CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
608160 | USD |
| CY2015Q4 | us-gaap |
Assets
Assets
|
16034490 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
11402230 | USD |
| CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1264876 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11402230 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7358840 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8770049 | USD |
| CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5497513 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
11714211 | USD |
| CY2013 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
5666 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3387115 | USD |
| CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
16625270 | USD |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13276186 | USD |
| CY2014 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
4606 | USD |
| CY2015 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
5232 | USD |
| CY2013 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
289657 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-5796 | USD |
| CY2014 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-104405 | USD |
| CY2015 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-281757 | USD |
| CY2014 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1050095 | USD |
| CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-44956 | USD |
| CY2015 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
192489 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-7678493 | USD |
| CY2015 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
0 | USD |
| CY2014 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-50874 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-13099853 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
227308 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
478760 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
998434 | USD |
| CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4083606 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8019137 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7766222 | USD |
| CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9187348 | USD |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-12.28 | |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
715524 | shares |
| CY2015 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | USD |
| CY2014 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
50874 | USD |
| CY2013 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
376306 | USD |
| CY2014 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
145100 | USD |
| CY2015 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
222592 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
289873 | USD |
| CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
302415 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
189318 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
162474 | USD |
| CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
116704 | USD |
| CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
409344 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
195454 | USD |
| CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
447541 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
199975 | USD |
| CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
594606 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-227308 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-594606 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
26232 | USD |
| CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
3240887 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9195753 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
20141703 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7932033 | USD |
| CY2015 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
3206357 | USD |
| CY2014 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
0 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
16935346 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7932033 | USD |
| CY2015 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
0 | USD |
| CY2014 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
4418824 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-86079 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
496275 | USD |
| CY2013 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
150663 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
245843 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-175529 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-119932 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-52748 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
65535 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-54635 | USD |
| CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-108907 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-6554908 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
86079 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8699478 | USD |
| CY2013 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-285295 | USD |
| CY2013 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-376306 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7155191 | USD |
| CY2013 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
0 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7137262 | USD |
| CY2013 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
4011205 | USD |
| CY2015Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
432437 | USD |
| CY2014Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
209426 | USD |
| CY2015Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
616863 | USD |
| CY2014Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
470314 | USD |
| CY2014Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
148921 | USD |
| CY2015 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
0 | USD |
| CY2015 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
148921 | USD |
| CY2015Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
0 | USD |
| CY2013Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
110608 | USD |
| CY2014 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
302758 | USD |
| CY2014 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
264445 | USD |
| CY2015Q4 | nuro |
Accrued Consulting Fees
AccruedConsultingFees
|
92000 | USD |
| CY2015Q4 | nuro |
Technology Fees
TechnologyFees
|
450000 | USD |
| CY2014Q4 | nuro |
Technology Fees
TechnologyFees
|
450000 | USD |
| CY2014Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
34206 | USD |
| CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
104399 | USD |
| CY2014Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
212137 | USD |
| CY2015Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
336229 | USD |
| CY2014Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
257024 | USD |
| CY2015Q4 | nuro |
Clinical Study Obligations
ClinicalStudyObligations
|
0 | USD |
| CY2014Q4 | nuro |
Clinical Study Obligations
ClinicalStudyObligations
|
74000 | USD |
| CY2015Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
56284 | USD |
| CY2015Q4 | nuro |
Accrued Personnel Related Obligations
AccruedPersonnelRelatedObligations
|
15548 | USD |
| CY2014Q4 | nuro |
Accrued Personnel Related Obligations
AccruedPersonnelRelatedObligations
|
37761 | USD |
| CY2015Q4 | nuro |
Accrued Federal Excise Tax
AccruedFederalExciseTax
|
1023 | USD |
| CY2014Q4 | nuro |
Accrued Federal Excise Tax
AccruedFederalExciseTax
|
25989 | USD |
| CY2014Q4 | nuro |
Accrued Consulting Fees
AccruedConsultingFees
|
173759 | USD |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
1865498 | USD |
| CY2015Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
1865498 | USD |
| CY2015Q4 | nuro |
Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
|
280303 | USD |
| CY2015Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
280303 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
4107478 | USD |
| CY2014Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
4107478 | USD |
| CY2014Q4 | nuro |
Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
|
5307307 | USD |
| CY2014Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
5307307 | USD |
| CY2014Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
2500000 | USD |
| CY2015 | us-gaap |
Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
|
2017-01-15 | |
| CY2015Q4 | nuro |
Restricted Cash Collateral Letters Of Credit
RestrictedCashCollateralLettersOfCredit
|
226731 | USD |
| CY2015Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
2300000 | USD |
| CY2015 | dei |
Document Type
DocumentType
|
10-K | |
| CY2015 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2015 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2015-12-31 | |
| CY2015 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2015 | |
| CY2015 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2015 | dei |
Entity Registrant Name
EntityRegistrantName
|
NeuroMetrix, Inc. | |
| CY2015 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001289850 | |
| CY2015 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2015 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2015 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2015 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2015 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2015Q2 | dei |
Entity Public Float
EntityPublicFloat
|
10242247 | USD |
| CY2015 | dei |
Trading Symbol
TradingSymbol
|
NURO | |
| CY2016Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4049807 | shares |
| CY2015 | nuro |
Minimum Closing Bid Price In Market
MinimumClosingBidPriceInMarket
|
1.00 | |
| CY2015 | nuro |
Minimum Bid Closing Price Of Ten Consecutive Business Days Per Shares
MinimumBidClosingPriceOfTenConsecutiveBusinessDaysPerShares
|
1.00 | |
| CY2015Q4 | nuro |
Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
|
1-for-4 | |
| CY2015 | nuro |
Common Stock Outstanding Immediately Prior To Reverse Stock Split
CommonStockOutstandingImmediatelyPriorToReverseStockSplit
|
13785239 | shares |
| CY2015 | us-gaap |
Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
|
3446274 | shares |
| CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
90111 | USD |
| CY2014Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
39966 | USD |
| CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
2362259 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4047332 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4047332 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2038151 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2038151 | shares |
| CY2015Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
16373052 | shares |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
517566 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
529537 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
541508 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
553479 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
475408 | USD |
| CY2015Q4 | nuro |
Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
|
487379 | USD |
| CY2015Q4 | nuro |
Operating Leases Future Minimum Payments Due In Seven Years
OperatingLeasesFutureMinimumPaymentsDueInSevenYears
|
81562 | USD |
| CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
3186439 | USD |
| CY2015 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
679026 | USD |
| CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
638679 | USD |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
635004 | USD |
| CY2015Q4 | us-gaap |
Purchase Obligation
PurchaseObligation
|
1526459 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8800422 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
245843 | USD |
| CY2013 | nuro |
Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
|
876786 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
| CY2013 | nuro |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
2617222 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
26285 | USD |
| CY2013 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
285295 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
289873 | USD |
| CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
302415 | USD |
| CY2014 | nuro |
Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
|
3539947 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
37824 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
24137 | USD |
| CY2014 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
104405 | USD |
| CY2015 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
281757 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7194975 | USD |
| CY2015 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2014 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD |
| CY2013 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
151558 | USD |
| CY2014 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
2955668 | USD |
| CY2015 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
0 | USD |
| CY2014 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
0 | USD |
| CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
17929 | USD |
| CY2015 | nuro |
Reclassification Of Warrant Liability To Additional Paid In Capital Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponExerciseOfWarrants
|
0 | USD |
| CY2014 | nuro |
Reclassification Of Warrant Liability To Additional Paid In Capital Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponExerciseOfWarrants
|
0 | USD |
| CY2013 | nuro |
Reclassification Of Warrant Liability To Additional Paid In Capital Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponExerciseOfWarrants
|
2362259 | USD |
| CY2015 | us-gaap |
Equity Method Investment Net Sales Proceeds
EquityMethodInvestmentNetSalesProceeds
|
16800000 | USD |
| CY2015Q4 | nuro |
Finished Goods On Consignment
FinishedGoodsOnConsignment
|
39784 | USD |
| CY2014Q4 | nuro |
Finished Goods On Consignment
FinishedGoodsOnConsignment
|
0 | USD |
| CY2015 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.19 | pure |
| CY2014 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.19 | pure |
| CY2013 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.16 | pure |
| CY2015Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
10484 | USD |
| CY2014Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1784 | USD |
| CY2015 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
2499000 | USD |
| CY2014 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
481000 | USD |
| CY2013 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
151000 | USD |
| CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5694372 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
963556 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
559878 | shares |
| CY2015 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
4140446 | USD |
| CY2013 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
766872 | USD |
| CY2015 | nuro |
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features
ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures
|
589751 | USD |
| CY2014 | nuro |
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features
ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures
|
0 | USD |
| CY2013 | nuro |
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features
ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures
|
0 | USD |
| CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-21070255 | USD |
| CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-10721890 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8786009 | USD |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2999717 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2827566 | USD |
| CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2316183 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2516046 | USD |
| CY2015 | us-gaap |
Depreciation
Depreciation
|
222592 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
145100 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
150663 | USD |
| CY2015 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
19000000 | USD |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.085 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.070 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.048 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.145 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.036 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.034 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.013 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.010 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.017 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0.109 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.583 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.347 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.371 | pure |
| CY2015 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
40397318 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
35449695 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2005741 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1855586 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
704957 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
657132 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
538321 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
590006 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
13698 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
208 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
19.45 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
28.67 | |
| CY2015Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P8Y3M18D | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y10M24D | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y3M18D | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
0 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
208 | shares |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
13506 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
43660035 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
38565925 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
43660035 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
38565925 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
18.81 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.70 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.70 | pure |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
190481 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
31376 | shares |
| CY2015 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
7044 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
214813 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
204310 | shares |
| CY2015 | nuro |
Number Of Shares Authorized To With Holding In Lieu Of Paying With Holding Taxes
NumberOfSharesAuthorizedToWithHoldingInLieuOfPayingWithHoldingTaxes
|
0 | shares |
| CY2014 | nuro |
Number Of Shares Authorized To With Holding In Lieu Of Paying With Holding Taxes
NumberOfSharesAuthorizedToWithHoldingInLieuOfPayingWithHoldingTaxes
|
0 | shares |
| CY2013 | nuro |
Number Of Shares Authorized To With Holding In Lieu Of Paying With Holding Taxes
NumberOfSharesAuthorizedToWithHoldingInLieuOfPayingWithHoldingTaxes
|
1054 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
118822 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.07 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
8.05 | |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
212500 | shares |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.95 | |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2015Q4 | nuro |
Income Tax Expense Benefit Attributable To Net Operating Loss Carry Forward
IncomeTaxExpenseBenefitAttributableToNetOperatingLossCarryForward
|
3900000 | USD |
| CY2015Q4 | nuro |
Income Tax Expense Benefit Attributable To Tax Credit Carry Forwards
IncomeTaxExpenseBenefitAttributableToTaxCreditCarryForwards
|
71000 | USD |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.70 | pure |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
0 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
0 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
7.60 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
7.60 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
0 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.24 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.08 | |
| CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
| CY2015Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
288000 | USD |
| CY2015Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
214813 | shares |
| CY2015Q4 | nuro |
Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Price Per Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAveragePricePerShares
|
11.18 | |
| CY2015 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y1M6D | |
| CY2013 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
500 | shares |
| CY2015 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
38000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
24000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
26000 | USD |
| CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
302000 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
290000 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
246000 | USD |
| CY2015 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <h2 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> </h2> <h3 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 24px; PADDING-RIGHT: 0pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates and Assumptions</h3> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances and regularly assesses these estimates, but actual results could differ materially from these estimates. Effects of changes in estimates are recorded in the period in which they occur.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Preferred Stock Modification
DeemedDividendsAttributableToPreferredStockInConnectionWithPreferredStockModification
|
8332212 | USD |
| CY2014 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Preferred Stock Modification
DeemedDividendsAttributableToPreferredStockInConnectionWithPreferredStockModification
|
0 | USD |
| CY2013 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Preferred Stock Modification
DeemedDividendsAttributableToPreferredStockInConnectionWithPreferredStockModification
|
0 | USD |
| CY2015 | nuro |
Issuance Of Preferred Stock And Warrants Under Underwritten Public Offerieng Value
IssuanceOfPreferredStockAndWarrantsUnderUnderwrittenPublicOfferiengValue
|
13290379 | USD |
| CY2015 | nuro |
Stock Issued During Period Value Redemption Of Preferred Stock
StockIssuedDuringPeriodValueRedemptionOfPreferredStock
|
2262934 | USD |
| CY2015 | nuro |
Stock Issued During Period Values Preferred Stock And Warrants
StockIssuedDuringPeriodValuesPreferredStockAndWarrants
|
6713500 | USD |
| CY2015 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <h3 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 24px; PADDING-RIGHT: 0pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Concentrations of Credit Risk</font></h3> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents in bank deposit accounts and trade receivables. The Company invests its funds in highly rated institutions and limits its investment in any individual account so that they do not exceed FDIC limits. The Company has not experienced significant losses related to cash and cash equivalents and does not believe it is exposed to any significant credit risks relating to its cash and cash equivalents.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">At December 31, 2015, one customer accounted for 46% of accounts receivable. For the year ended December 31, 2015 one customer accounted for 12% of revenue. For the year ended December 31, 2014 one customer accounted for more than 30% of revenue. For the year ended December 31, 2013, one customer accounted for more than 10% of revenue.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company relies on in-house assembly and three third-party manufacturers to manufacture the major portion of its current products and product components. The disruption or termination of the supply of these products or a significant increase in the cost of these products from these sources could have an adverse effect on the Company’s business, financial position, and results of operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013 | nuro |
Equity Offering Costs Included In Accounts Payable And Accrued Expenses
EquityOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
0 | USD |
| CY2015 | nuro |
Equity Offering Costs Included In Accounts Payable And Accrued Expenses
EquityOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
100000 | USD |
| CY2014 | nuro |
Equity Offering Costs Included In Accounts Payable And Accrued Expenses
EquityOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
0 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
|
45000 | USD |
